Assessment of women’s treatment preferences for vasomotor symptoms due to menopause

References

• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–395. doi: 10.1097/gme.0b013e31824d8f40
   PubMed Web of Science ®Google Scholar
• Whiteley J, DiBonaventura M, Wagner JS, et al. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health (Larchmt). 2013;22(11):983–990. doi: 10.1089/jwh.2012.3719
   PubMed Web of Science ®Google Scholar
• Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–539. doi: 10.1001/jamainternmed.2014.8063
   PubMed Web of Science ®Google Scholar
• Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women’s Health Across the Nation. Am J Public Health. 2006;96(7):1226–1235. doi: 10.2105/AJPH.2005.066936
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn ovarian aging study cohort. Menopause. 2014;21(9):924–932. doi: 10.1097/GME.0000000000000196
   PubMed Web of Science ®Google Scholar
• Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008;11(1):32–43. doi: 10.1080/13697130701744696
   PubMed Web of Science ®Google Scholar
• Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153(9):865–874. doi: 10.1093/aje/153.9.865
   PubMed Web of Science ®Google Scholar
• NAMS. Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017;24(7):728–753. doi: 10.1097/GME.0000000000000921
   PubMed Web of Science ®Google Scholar
• Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol. 2012;120(3):595–603. doi: 10.1097/AOG.0b013e318265df42
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310(13):1353–1368. doi: 10.1001/jama.2013.278040
   PubMed Web of Science ®Google Scholar
• Arbuckle R, Humphrey L, Abraham L, et al. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in postmenopausal women to inform the development of new patient-reported measurement tools. Maturitas. 2014;78(3):219–227. doi: 10.1016/j.maturitas.2014.04.019
   PubMed Web of Science ®Google Scholar
• Abraham L, Humphrey L, Arbuckle R, et al. Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools. Maturitas. 2015;80(3):273–281. doi: 10.1016/j.maturitas.2014.11.019
   PubMed Web of Science ®Google Scholar
• Ameye L, Antoine C, Paesmans M, et al. Menopausal hormone therapy use in 17 European countries during the last decade. Maturitas. 2014;79(3):287–291. doi: 10.1016/j.maturitas.2014.07.002
   PubMed Web of Science ®Google Scholar
• Williams-Frame A, Carpenter JS. Costs of hormonal and nonhormonal prescription medications for hot flashes. Womens Health (Lond Engl). 2009;5(5):497–502. doi: 10.2217/WHE.09.49
   PubMedGoogle Scholar
• Kjerulff KH, Frick KD, Rhoades JA, et al. The cost of being a woman: a national study of health care utilization and expenditures for female-specific conditions. Womens Health Issues. 2007;17(1):13–21. doi: 10.1016/j.whi.2006.11.004
   PubMed Web of Science ®Google Scholar
• Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015;22(3):260–266. doi: 10.1097/GME.0000000000000320
   PubMed Web of Science ®Google Scholar
• Tao M, Teng Y, Shao H, et al. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One. 2011;6(9):e24661. doi: 10.1371/journal.pone.0024661
   PubMed Web of Science ®Google Scholar
• Clark HD, O’Connor AM, Graham ID, et al. What factors are associated with a woman’s decision to take hormone replacement therapy? Evaluated in the context of a decision aid. Health Expect. 2003;6(2):110–117. doi: 10.1046/j.1369-6513.2003.00216.x
   PubMedGoogle Scholar
• Constantine GD, Graham S, Clerinx C, et al. Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reprod Health. 2016;22(3):112–122. doi: 10.1177/2053369116632439
   PubMedGoogle Scholar
• Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics. 2008;26(8):661–677. doi: 10.2165/00019053-200826080-00004
   PubMed Web of Science ®Google Scholar
• Johnson FR, Yang JC, Reed SD. The internal validity of discrete choice experiment data: a testing tool for quantitative assessments. Value Health. 2019;22(2):157–160. doi: 10.1016/j.jval.2018.07.876
   PubMed Web of Science ®Google Scholar
• Speckemeier C, Krabbe L, Schwenke S, et al. Discrete choice experiment to determine preferences of decision-makers in healthcare for different formats of rapid reviews. Syst Rev. 2021;10(1):121. doi: 10.1186/s13643-021-01647-z
   PubMed Web of Science ®Google Scholar
• de Bekker-Grob EW, Donkers B, Jonker MF, et al. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–384. doi: 10.1007/s40271-015-0118-z
   PubMedGoogle Scholar
• Yang JC, Johnson FR, Kilambi V, et al. Sample size and utility-difference precision in discrete-choice experiments: a meta-simulation approach. J Choice Model. 2015;16:50–57. doi: 10.1016/j.jocm.2015.09.001
   Web of Science ®Google Scholar
• English M, Stoykova B, Slota C, et al. Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS sleep disturbance and sleep-related impairment measures for assessment of VMS impact on sleep. J Patient Rep Outcomes. 2021;5(1):37. doi: 10.1186/s41687-021-00289-y
   PubMedGoogle Scholar
• Pinkerton JV, Abraham L, Bushmakin AG, et al. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Menopause. 2016;23(10):1060–1066. doi: 10.1097/GME.0000000000000678
   PubMed Web of Science ®Google Scholar
• Cumming GP, Currie H, Morris E, et al. The need to do better – are we still letting our patients down and at what cost? Post Reprod Health. 2015;21(2):56–62. doi: 10.1177/2053369115586122
   PubMedGoogle Scholar
• Nappi RE, Kroll R, Siddiqui E, et al. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden. Menopause. 2021;28(8):875–882. doi: 10.1097/GME.0000000000001793
   PubMed Web of Science ®Google Scholar
• Ancker JS, Senathirajah Y, Kukafka R, et al. Design features of graphs in health risk communication: a systematic review. J Am Med Inform Assoc. 2006;13(6):608–618. doi: 10.1197/jamia.M2115
   PubMed Web of Science ®Google Scholar
• Arnot M, Emmott EH, Mace R, et al. The relationship between social support, stressful events, and menopause symptoms. PLoS One. 2021;16(1):e0245444. doi: 10.1371/journal.pone.0245444
   PubMed Web of Science ®Google Scholar
• Refaei M, Mardanpour S, Masoumi SZ, et al. Women’s experiences in the transition to menopause: a qualitative research. BMC Womens Health. 2022;22(1):53. doi: 10.1186/s12905-022-01633-0
   PubMed Web of Science ®Google Scholar
• Trémollieres FA, André G, Letombe B, et al. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management. Maturitas. 2022;166:58–64. doi: 10.1016/j.maturitas.2022.08.003
   PubMed Web of Science ®Google Scholar
• Smith K. The funding gender gap: nature. [13 Jul 2023]. Available from: https://www.nature.com/immersive/d41586-023-01475-2/assets/d41586-023-01475-2.pdf
   Google Scholar